Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA, U7 small nuclear 60 pseudogene (RNU7-60P) is a non-coding RNA pseudogene found in the human genome, related in sequence to the U7 small nuclear RNA gene family. The canonical U7 snRNA is an essential component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which plays a critical role in 3' end processing of histone pre-mRNAs[4][3]. In contrast, RNU7-60P lacks evidence of protein-coding potential or functional small nuclear RNA activity and is classified as a pseudogene—a genetic element that resembles a functional gene but is generally transcriptionally inactive and not known to contribute to cellular processes or disease pathogenesis[5]. Functional U7 snRNA is involved in histone mRNA maturation by binding to the histone downstream element (HDE) to facilitate cleavage and polyadenylation of pre-mRNA[4]. Mutations in functional U7 snRNA genes (e.g., RNU7-1), not pseudogenes like RNU7-60P, are associated with diseases such as Aicardi-Goutières syndrome[1][2]. RNU7-60P is annotated by multiple genomic resources as a pseudogene, not as a biologically active molecule[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 60 pseudogene (RNU7-60P).